article thumbnail

Three Big Questions for Stage 3 & Patient Engagement

Chilmark Research

For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. Evidence for the positive impact of this data on quality, satisfaction, and in some cases cost is thin but growing.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices. The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices. The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices. The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices. The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices.

article thumbnail

FDA and Digital Health Regulation

Health Blawg

The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices. The agency has a history of articulating its position on where the line is to be drawn, on how it is to exercise its discretion in regulating devices.